• Skip to main content
  • Skip to footer

PeDRA

Pediatric Dermatology Research Alliance

  • DONATE
  • Pay 2022 Membership Dues
  • Join PeDRA
  • Login
MENUMENU
  • Contact Us
  • For Patients & Families
        • Patient Support
        • Patient Education
        • Community Spotlight
        • Clinical Trials
        • Patient Advisory Committee
        • Find a Pediatric Dermatologist (from SPD)
        • Parents, advocates, and patients over the age of 18 with a direct connection or significant interest in childhood skin disease or pediatric dermatology research are encouraged to join the PeDRA network for free as Community Members.

          Apply Now!

  • Education and Events
        • Virtual Education
        • Points of Discussion Podcast
        • Mentorship Program
        • Education Archive
        • 2022 PeDRA Annual Conference
        • Early Investigator Support
        • Dash for Discovery Fun Run/Walk
        • Events Calendar
        • Subscribe to the PeDRA Pearls Podcast channel on iTunes, Google Podcasts, or Spotify.

  • Research
        • Grants & Awards
        • Resources for Researchers
        • Survey Application
        • Study Application
        • Research Areas
        • Publications
        • Clinical Trials
        • 2022 Childhood Eczema Challenge Grant applications are now being accepted with a June 1st deadline.

  • About
        • Mission & Vision
        • Leadership & Staff
        • Annual Reports & Financials
        • News Archive
        • Our Supporters
        • Our Membership
        • Our Committees
        • Getting to Know You
        • NOW HIRING! Explore current opportunities at PeDRA.

  • Member Login

Drugs and Bugs

Clinical and Genetic Characterization of Recurrent Reactive Infectious Mucocutaneous Eruption

April 13, 2021 By Katherine Devenport




Principal Investigators:

Yvonne Chiu, MD
Medical College of Wisconsin

Michele Ramien, MD
University of Calgary

Beth Drolet, MD
University of Wisconsin, Madison

Overview:

Reactive infectious mucocutaneous eruption (RIME) is a condition activated by an infection, resulting in blisters on the skin and widespread sores on mucous membranes. RIME is rare but most commonly affects children and adolescents. Recurrent RIME, where people have multiple episodes of RIME, is even more rare.

Recent research studies have shown that genetic differences can affect how children respond to common viral infections. We hypothesize that people who have RIME have genetic differences that cause an abnormal hyper-inflammatory response to common infections, and that people with recurrent RIME have even stronger genetic susceptibility.

The medical community does not know much about RIME or how to treat it. We would like to characterize RIME and recurrent RIME, describing the clinical features, the immunologic profile, and discovering genetic variants. We hope that if we can understand what makes children have RIME, we will be able to treat the disease more effectively.

Status:

This project was funded by a 2020 PeDRA Research Grant.

Filed Under: Drugs and Bugs

Footer

  • Our Membership
  • For Patients
  • For Researchers
  • Governance Policies
  • Financial Conflict of Interest Policy
  • Jobs at PeDRA
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
Sign up to receive emails from PeDRA
Join PeDRA
Donate

Copyright © 2022 · Pediatric Dermatology Research Alliance (PeDRA) · All Rights Reserved. · Privacy Policy